LUNG INFECTION in ICU (LUNG-I3)

Recruiting Observational Study
VAP - Ventilator Associated Pneumonia
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
68 (estimated)
Sponsor
BioMérieux · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

objective of LUNG-I3 study is to assess the quantitative and functional differences in cells between blood and bronchoalveolar lavage (BAL) fluid after an infection, with a special focus on alveolar macrophages and neutrophils

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: All the following criteria * Age 18 years or greater * Severe ICU patients hospitalized for one of the above diseases: * Septic shock (requirement of vasopressor to maintain a mean arterial pressure of 65 mm Hg or greater and serum lactate level greater than 2 mmol/L (\>18 m…
Contacts

Jean-François LLITJOS

+33761568397

jeanfrancois.llitjos@biomerieux.com

CONTACT

Marie-Angelique CAZALIS

+33626807839

marie-angelique.cazalis@biomerieux.com

CONTACT